Andrew B. Katims, Neeta D'Souza, M. J. Escano, Gamze Gokturk, Merve Basar, David B. Solit, Gopakumar Iyer, B. Bochner, Alvin Goh, Timothy A. Donahue, Judy Sarungbam, Oscar Lin, H. Al-Ahmadie, E. Pietzak, Mark Farha
{"title":"原位癌和尿液细胞学作为接受 BCG 治疗的非肌层浸润性膀胱癌患者最小残留病灶的指标","authors":"Andrew B. Katims, Neeta D'Souza, M. J. Escano, Gamze Gokturk, Merve Basar, David B. Solit, Gopakumar Iyer, B. Bochner, Alvin Goh, Timothy A. Donahue, Judy Sarungbam, Oscar Lin, H. Al-Ahmadie, E. Pietzak, Mark Farha","doi":"10.1016/j.urolonc.2024.01.145","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":506909,"journal":{"name":"Urologic Oncology: Seminars and Original Investigations","volume":"35 11","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"CARCINOMA IN SITU AND URINARY CYTOLOGY AS AN INDICATOR OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER TREATED WITH BCG\",\"authors\":\"Andrew B. Katims, Neeta D'Souza, M. J. Escano, Gamze Gokturk, Merve Basar, David B. Solit, Gopakumar Iyer, B. Bochner, Alvin Goh, Timothy A. Donahue, Judy Sarungbam, Oscar Lin, H. Al-Ahmadie, E. Pietzak, Mark Farha\",\"doi\":\"10.1016/j.urolonc.2024.01.145\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":506909,\"journal\":{\"name\":\"Urologic Oncology: Seminars and Original Investigations\",\"volume\":\"35 11\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Urologic Oncology: Seminars and Original Investigations\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.urolonc.2024.01.145\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urologic Oncology: Seminars and Original Investigations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.urolonc.2024.01.145","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
CARCINOMA IN SITU AND URINARY CYTOLOGY AS AN INDICATOR OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER TREATED WITH BCG